The 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guideline recommends lower levels of both systolic and diastolic blood pressure (BP) for defining hypertension, 1 and implementation of the new guideline is expected to increase the prevalence of hypertension and use of antihypertensive medication, and reduce cardiovascular disease events in the United States. 2 Vascular aging progressively increases systolic BP and lowers diastolic BP, and is the major pathophysiology for the development of hypertension in the elderly population. 3 Apparently, lowering systolic BP threshold has a much greater impact on the diagnosis of hypertension than lowering diastolic BP threshold in an elderly population.
The 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guideline recommends lower levels of both systolic and diastolic blood pressure (BP) for defining hypertension, 1 and implementation of the new guideline is expected to increase the prevalence of hypertension and use of antihypertensive medication, and reduce cardiovascular disease events in the United States. 2 Vascular aging progressively increases systolic BP and lowers diastolic BP, and is the major pathophysiology for the development of hypertension in the elderly population. 3 Apparently, lowering systolic BP threshold has a much greater impact on the diagnosis of hypertension than lowering diastolic BP threshold in an elderly population.
Central systolic BP is usually lower than brachial systolic BP, and the former is a better indicator of vascular aging than the latter. As vascular aging is a major risk factor of cardiovascular disease events independent of conventional risk factors, central BP might be better than brachial BP in prediction of cardiovascular outcomes. 4 It has been shown that using cuff brachial BP to diagnose hypertension may substantially underestimate the prevalence of hypertension, 5 because of the limited accuracy of brachial cuff BP. 6 Instead, hypertension defined by central BP thresholds of ≥130/90 mm Hg may have a greater discriminatory power for longterm events. 7 Using a cuff-based stand-alone central BP monitor purporting to measure invasive central BP (type II device), 8 we have shown that a substantial proportion of subjects with the central hypertension could not be identified using a conventional brachial BP approach in a national representative population in Taiwan. 9 Taiwan is one of the fastest-aging societies in the world, 10 and vascular aging would substantially increase the burden of hypertension control at present and in the near future. 3 In this study, we therefore estimated the prevalence of brachial hypertension according to the 2017 ACC/AHA guideline and examined the concordance between the brachial hypertension and central hypertension in the same national representative population. 9 
MATERIAL AND METHODS
The sampling and enrollment of the national representative population for the 2013-2016 National Nutrition and Health Survey in Taiwan (NAHSIT) has previously been reported. 9 In brief, NAHSIT 2013-2016 was aimed to investigate the nutrition status and the association between nutrition/ diet and disease in residents in Taiwan. All residents in the National Household Registry in Taiwan were candidates, excluding those who lived in military institutes, medical institutes, schools, occupation/sport training centers, dormitories, and prisons. Enrolled subjects in the NAHSIT were selected using a multistage stratified sampling scheme. Informed consent was obtained from each participant before the household interview. All subjects who had received the household interview were invited for a health checkup, including fasting blood, biochemical, and urine sample testing, and central and brachial BP measurements. A total of 2,742 residents aged more than 19 years attended the health checkup.
BP measurement and definitions of brachial and central hypertension
All participants were asked to refrain from exercise, smoking, and drinking tea or coffee before BP measurement. BP measurement was carried out between 8 am and 12 noon while subjects had been seated and relaxed for 5 minutes with back and arms supported, legs uncrossed, and feet flat on the floor in a quiet room at each survey site for the health checkup. 11 Central and brachial BPs were measured simultaneously in the right arm with an appropriately sized cuff at heart level, using an oscillometric central BP monitor (WatchBP Office Central; Microlife AG, Widnau, Switzerland). 12 The central BP monitor measured brachial systolic and diastolic BP, performed pulse volume plethysmography at cuff pressure of 60 mm Hg to provide an ensemble average brachial pressure waveform, calibrated the ensemble average waveform to the brachial systolic and diastolic BPs, analyzed the calibrated waveform, and finally calculated central systolic BP and pulse pressure (PP) according to separate regression equations constructed from components of the analyzed waveform. 12, 13 Measurement accuracy of the stand-alone oscillometric central BP monitor with reference to the simultaneously measured invasive central BP in 85 subjects has been previously reported. 12 The mean differences of central systolic BP, PP, and diastolic BP with reference to the invasively measured central BPs were −0.6 ± 5.5, −0.4 ± 7.0, and −0.2 ± 6.5 mm Hg, respectively, without obvious systematic bias. 12 The central BP monitor displayed readings of brachial systolic and diastolic BPs, central systolic BP and PP, and heart rate, each of which was an average from 2 consecutive measurements separated by an interval of 60 second. Central diastolic BP was calculated as the difference between central systolic BP and PP. 12 Normal brachial BP was defined as brachial systolic BP < 120 mm Hg and diastolic BP < 80 mm Hg in subjects without using antihypertensive medication. 1 Elevated brachial BP was defined as brachial systolic BP 120-129 mm Hg and diastolic BP < 80 mm Hg in subjects without using antihypertensive medication. 1 Brachial hypertension was defined as brachial systolic BP ≥ 130 mm Hg or diastolic BP ≥ 80 mm Hg or using antihypertensive medication. 1 In subjects with brachial hypertension, isolated brachial systolic hypertension was defined as brachial systolic BP ≥ 130 mm Hg and diastolic BP < 80 mm Hg; isolated brachial diastolic hypertension was defined as brachial systolic BP < 130 mm Hg and diastolic BP ≥ 80 mm Hg; combined brachial systolic/diastolic hypertension was defined as brachial systolic BP ≥ 130 mm Hg and diastolic BP ≥ 80 mm Hg.
Central hypertension was defined as central systolic BP ≥ 130 mm Hg or diastolic BP ≥ 90 mm Hg or using antihypertensive medication. 7, 9 Other definitions Diabetes was defined as fasting glucose ≥126 mg/dl or using antidiabetic medication. Dyslipidemia was defined as total cholesterol ≥200 mg/dl or low-density lipoprotein cholesterol ≥130 mg/dl or using lipid lowering medication. All subjects were asked about the tobacco exposure status using the questionnaire of "Do you have a habit of smoking?" and a "Yes" answer was categorized as current smoking. Physical activity was measured using the international physical activity questionnaire. Physical inactivity was defined as no activity is reported or some activity is reported but not enough to meet a moderate or high activity category. 14 
10-year coronary heart disease risk score
The 10-year coronary heart disease risk score for everyone was calculated using a simple point system (18 total points) for the clinical model developed from 3,430 Taiwanese participants followed up for a median 15.9 years. 9, 15 The performance of the clinical model, incorporating age (0-8 points), gender (0-2 points), body mass index (0-4 points), systolic BP (0-3 points), and smoking status (1 point), was not inferior to the cholesterol-based model and Framingham model in the external validation dataset. 15 
Statistical methods
Means (±SD) and proportions were used to describe the characteristics of the national representative population. The analysis of variance method with Scheffe's multiple comparison and chi-square test were used to examine the difference in intervals and proportions between BP categories, respectively. National weighted prevalence rates of central and brachial hypertension were estimated accounting for sampling scheme in the sampled population using SAS-callable SUDDAN. We also estimated the standardized prevalence rates of central and brachial hypertension using the World Health Organization (WHO) 2000 world standardized population. 16, 17 The sensitivity, specificity, false-positive rate, and falsenegative rate were calculated with central hypertension as the true disease, and conventional brachial hypertension (≥140/90 mm Hg) and 2017 AHA/ACC brachial hypertension (≥130/80 mm Hg) guideline were used as screening tools. The concordance rate and kappa index were also calculated.
Comparisons between subjects with concordant central and brachial nonhypertension, isolated central hypertension, isolated brachial hypertension, and concordant central and brachial hypertension were performed with multiple comparison test or chi-square test where appropriate.
We further used the multivariable logistic regression with stepwise selection from candidates of all significant variables in univariate analyses to identify the independent determinants of isolated central hypertension among subjects without brachial hypertension, and of isolated brachial hypertension among subjects with brachial hypertension.
All statistical tests were set at a type I error of 5% and 2 tails. P values of <0.05 were considered statistically significant.
RESULTS
The national representative sample of 2,742 adults older than 19 years were categorized as normal BP, elevated brachial BP and brachial hypertension according to 2017 ACC/AHA hypertension guideline and the characteristics of the 3 BP categories are shown in Table 1 . As expected, subjects with elevated brachial BP or brachial hypertension were older, had higher brachial and central systolic and diastolic BP and PP, body mass index, waist circumference, fasting blood levels of triglycerides, low-density lipoprotein cholesterol, total cholesterol, and glucose, had lower highdensity lipoprotein cholesterol, and had higher prevalence of diabetes and dyslipidemia, in comparison to subjects with normal brachial BP. No significant difference in the prevalence of smoking was observed among the 3 BP categories. In subjects with brachial hypertension, 74.4% would also be defined as brachial hypertension according to the conventional brachial BP thresholds of ≥140/90 mm Hg. The crude prevalence of central hypertension was 0.60% in the normal brachial BP category, 25.7% in the elevated brachial BP category, and 85.6% in the brachial hypertension category.
Prevalence of brachial hypertension according to the 2017 ACC/AHA guideline
The WHO-age standardized prevalence of brachial hypertension was 34.5% (43.5% for men and 26.0% for women) ( Table 2 ). The national weighted prevalence of brachial hypertension was 39.1% (48.7% for men and 30.4% for women) ( Table 2 ). The national weighted prevalence of central hypertension and brachial hypertension according to the conventional criteria and the 2017 ACC/AHA hypertension guideline stratified by sex and age groups are shown in Supplementary Table 1 . Adoption of the 2017 ACC/AHA guideline would therefore increase the national weighted prevalence of brachial hypertension by 18.8% in men and 9.1% in women, when compared with the corresponding figures of 29.9% in men and 21.3% in women, respectively, defined by the conventional BP thresholds of brachial systolic BP ≥ 140 mm Hg or diastolic BP ≥ 90 mm Hg. 9 The increase in the prevalence of brachial hypertension resulting from the lowering of BP thresholds by the 2017 ACC/AHA guideline was particularly remarkable in men aged less than 55 years ( Figure 1 ).
In men, the increase in the prevalence of brachial hypertension by the 2017 ACC/AHA hypertension guideline was attributed to a high diastolic BP only (≥80 mm Hg, 47%), a high systolic BP only (≥130 mm Hg, 24%), or both (29%) (Supplementary Figure 1) . In contrast, the corresponding figures in women were 33%, 44%, and 23%, respectively (Supplementary Figure 1) . Characteristics of the subjects who were initially categorized as nonhypertension according to the conventional BP thresholds but were recategorized as brachial hypertension according to the 2017 ACC/ AHA hypertension guideline are shown in Supplementary  Table 2 . Multivariable stepwise logistic regression analysis revealed that older age, a higher brachial systolic BP, waist circumference and triglyceride level, a history of diabetes and dyslipidemia, and a lower brachial PP, and total cholesterol level were independent correlates of the recategorized brachial hypertension (Supplementary Table 3 ).
Identification of central hypertension by brachial hypertension
The performance of brachial hypertension defined by the conventional BP thresholds or the 2017 AHA/ACC guideline in identifying central hypertension is shown in Table 3 . Lowering of the BP thresholds increased sensitivity and false-positive rate but decreased specificity and false-negative rate. Overall, the new hypertension criteria had a lower concordance rate (88.8% vs. 92.4%) and a lower kappa index (0.758 vs. 0.815) for detecting central hypertension.
Isolated central hypertension and isolated brachial hypertension
According to the 2017 ACC/AHA hypertension guideline and the central hypertension criteria, all subjects could be classified as concordant nonhypertension (nonbrachial hypertension and noncentral hypertension, n = 1,360, 49.6%), isolated central hypertension (n = 76, 2.8%), isolated brachial hypertension (n = 188, 6.9%), and concordant hypertension (brachial hypertension and central hypertension, n = 1,118, 40.8%) ( Table 4 ). The national weighted prevalence rates of concordant nonhypertension, isolated central hypertension, isolated brachial hypertension, and concordant hypertension were 58.6%, 2.3%, 8.9%, and 30.2%, respectively. 2017 ACC/AHA normal brachial BP: brachial SBP < 120 mm Hg and DBP < 80 mm Hg and without using antihypertensive medication. 2017 ACC/AHA elevated brachial BP: brachial SBP 120-129 or DBP < 80 mm Hg in subjects without using antihypertensive medication. Diabetes: fasting glucose ≥126 mg/dl or using diabetic medicines. Dyslipidemia: total cholesterol ≥200 mg/dl or LDL cholesterol ≥130 mg/dl or using lipids lowering drugs. Abbreviations: ACC/AHA = American College of Cardiology/American Heart Association; BP = blood pressure; DBP = diastolic BP; HDL = high-density lipoprotein; LDL = low-density lipoprotein; PP = pulse pressure; SBP = systolic BP. The prevalence of isolated brachial hypertension was remarkably higher than isolated central hypertension in the young and middle adults, especially in men (Figure 2 ). In men, the prevalence of isolated brachial hypertension remained higher than that of isolated central hypertension in the elderly women (Figure 2 ). In contrast, elderly women had a higher prevalence of isolated central hypertension than isolated brachial hypertension (Figure 2 ).
In subjects with isolated brachial hypertension, the prevalence of isolated brachial diastolic hypertension, combined brachial systolic/diastolic hypertension, and isolated brachial systolic hypertension was 70.2%, 22.3%, and 7.5%, respectively (Table 4 ). In contrast, in subjects with both brachial and central hypertension (concordant hypertension), the dominant phenotype was combined brachial systolic/diastolic hypertension (86.40%), followed by isolated brachial systolic hypertension (12.3%), then by isolated brachial diastolic hypertension (1.3%) ( Table 4) . Subjects with isolated central hypertension were older and characterized with a significantly higher central and brachial systolic BP, diastolic BP and PP, a greater body mass index and waist circumference, a higher prevalence of diabetes, and a lower high-density lipoprotein cholesterol level, in comparison with subjects without brachial or central hypertension (concordant nonhypertension) ( Table  4 ). In subjects without brachial hypertension (concordant nonhypertension + isolated central hypertension), multivariable stepwise logistic regression analysis revealed that only central systolic BP (mm Hg) (odds ratio 21.472, 95% confidence intervals 5.621-82.019, P < 0.0001) was significantly independently associated with isolated central hypertension.
On the other hand, subjects with isolated brachial hypertension were younger, predominantly men, and characterized with a significantly lower brachial and central systolic BP, diastolic BP and PP, lower body mass index, waist circumference, glucose level, a lower prevalence of diabetes and use of antidiabetic medication, a higher level of triglyceride, and a higher prevalence of smoking, in comparison with subjects with concordant nonhypertension. In subjects with brachial hypertension (concordant hypertension + isolated brachial hypertension), multivariable stepwise logistic regression analysis revealed that younger age (odds ratio 0.943, 95% confidence intervals 0.928-0.959, P < 0.0001), male sex (vs. female) (1.977, 1.248-3.132, P = 0.0037), higher brachial diastolic BP (mm Hg) (1.121, 1.090-1.152, P < 0.0001), lower central systolic BP (mm Hg) (0.846, 0.822-0.870, P < 0.0001), and lower body mass index (kg/m 2 ) (0.902, 0.848-0.958, P = 0.0008) were independently associated with isolated brachial hypertension.
Subjects with either isolated central hypertension or isolated brachial hypertension had a significantly higher estimated 10-year coronary heart disease risk score than those without brachial or central hypertension (concordant nonhypertension). On the other hand, subjects with concordant hypertension had the highest brachial systolic BP and PP, central systolic BP, waist circumference, fasting glucose, and estimated 10-year coronary heart disease risk score, when compared with the other groups. Brachial hypertension: brachial blood pressure ≥130/80 mm Hg or using antihypertensive medication (2017 ACC/AHA hypertension guideline). Central hypertension: central blood pressure ≥130/90 mm Hg or using antihypertensive medication. Brachial ISH: brachial systolic blood pressure ≥130 mm Hg and diastolic blood pressure <80 mm Hg. Brachial IDH: brachial systolic blood pressure <130 mm Hg and diastolic blood pressure ≥80 mm Hg. Brachial SDH: brachial systolic blood pressure ≥130 mm Hg and diastolic blood pressure ≥80 mm Hg. Abbreviations: DBP = diastolic blood pressure; HDL = high-density lipoprotein; IDH = isolated diastolic hypertension; ISH = isolated systolic hypertension; LDL = low-density lipoprotein; PP = pulse pressure; SBP = systolic blood pressure; SDH = combined systolic/diastolic hypertension.
a P value less than 0.05 for comparing with those without brachial or central hypertension (concordant nonhypertension). b P value less than 0.05 for comparison with those with isolated central hypertension. c P value less than 0.05 for comparison with those with isolated brachial hypertension.
DISCUSSION

Main findings
Almost half of men and one-third of women in Taiwan would be categorized as having brachial hypertension by the 2017 ACC/AHA guideline. The increased prevalence of brachial hypertension was mainly attributed to the high prevalence of isolated diastolic hypertension in the young and middle-aged adults (19-64.9 years), especially in men. The new brachial hypertension criteria were very sensitive in identifying central hypertension, at the expense of lesser specificity. The resultant "false positive" was a group of subjects with brachial hypertension but without central hypertension, namely, the isolated brachial hypertension. Isolated brachial hypertension was characterized by young age, male sex, and isolated diastolic hypertension, implying minimal evidence of the presence of arterial stiffness or vascular aging. Subjects with isolated brachial hypertension had an increased risk of coronary heart disease similar to those with isolated central hypertension, when compared with subjects without brachial or central hypertension (concordant nonhypertension). Moreover, subjects with concordant brachial and central hypertension had a significantly increased estimated 10-year coronary heart disease risk score than those with isolated brachial hypertension. Overall, our results may support the adoption of the 2017 ACC/AHA hypertension guideline for the diagnosis of brachial hypertension, and concomitant measurement of central BP may supplement the new brachial hypertension criteria by helping stratify the high-risk subjects from those with brachial hypertension and identify the remaining central hypertension in those without brachial hypertension. The ACC/AHA hypertension guideline lowers the brachial systolic and diastolic BP thresholds and therefore unavoidably increases the prevalence of brachial hypertension and its public burden. Among US adults, the crude prevalence of brachial hypertension reached 45.6% by the new criteria (from 31.9% by the conventional criteria). 2 Men had a greater increase in the brachial hypertension prevalence than women (17% [31%->48%] and 11% [32%->43%], respectively), and men aged less than 55 years increased more than 50%. In contrast, in Bangladesh, women had a higher prevalence than men (54.5% vs. 41.4%), and the prevalence of brachial hypertension doubly increased (from 25.7%->48.0%) among adults aged ≥35 years 18 by the new hypertension criteria and the increase of brachial hypertension prevalence was similar in both genders (22.0% vs. 22.6%). 18 In this study, men would have a higher increase of the prevalence of brachial hypertension than women (18.8% vs. 9.1%), and the increase would reach 50% in young men (aged less than 50 years), according to the 2017 ACC/AHA criteria. Therefore, the impact of the 2017 ACC/AHA hypertension guideline on the prevalence of hypertension and burden of hypertension control may vary substantially among populations.
The relationship between brachial hypertension and central hypertension: Impact of the 2017 ACC/AHA hypertension guideline Central BP might be a better predictor for cardiovascular outcomes than peripheral BP. 4 Conventional cuff brachial BP monitors usually underestimate intra-arterial brachial systolic BP and overestimate intra-arterial diastolic BP. 6 Cuff and intraarterial aortic systolic BP may show a small mean difference but poor agreement. 6 Therefore, cuff BP has variable accuracy for measuring either brachial or aortic intra-arterial BP, 6 and this may adversely influence the accuracy of hypertension prevalence. With reference to the intra-arterial aortic BP, we have shown that cuff brachial BP substantially underestimated the prevalence of central hypertension, according to the conventional brachial BP thresholds (≥140/90 mm Hg). 5 Moreover, in the same national representative population as the present one, 7.35% of adults with central hypertension were not identified by the cuff BP. 9 More importantly, those with the isolated central hypertension had a significantly higher risk of coronary heart disease than those with concordance nonhypertension. 9 In this study, adoption of the 2017 ACC/ AHA hypertension guideline would identify more subjects with true central hypertension but at the same time misclassify a substantial number of false-positive central hypertension so the concordance between brachial hypertension and central hypertension would not improve, as compared with the conventional hypertension criteria.
Isolated brachial hypertension and sex difference
In this study, a significant subgroup of subjects with isolated brachial hypertension (national weighted prevalence, 8.9%) was identified, based on the 2017 ACC/AHA hypertension guideline and the central hypertension criteria. 7 Subjects with the isolated brachial hypertension were predominantly young men with isolated diastolic hypertension. Male gender, middle age, overweight or obesity, smoking, and hypercholesterolemia were found to be relevant risk factors of isolated diastolic hypertension in adults. 19, 20 An 11-year follow-up study revealed that subjects with isolated diastolic hypertension defined with home BP measurements had an increased risk of cardiovascular events (hazard ratio 1.95, 95% confidence intervals 1.06-3.57) similar to those with isolated systolic hypertension (2.05; 1.42-3.05), when compared with normotensive subjects. 20 Our study also found that subjects with isolated brachial hypertension had a significantly higher coronary artery disease risk than those with concordant nonhypertension and the risk was equivalent to those with isolated central hypertension. Those with isolated brachial hypertension may be early treated by antihypertensive medication and may have the adverse drug effects. However, those subjects may also have benefits for early hypertension identification and early treatment for slower progression of hypertension.
Subjects with isolated brachial hypertension were predominantly young men with a high brachial diastolic BP and a low central systolic BP. They also had a low central PP, even significantly lower than that of subjects with concordant nonhypertension (Table 4) . A high central PP usually indicates the presence of significant arterial stiffness and vascular aging. 21 Conversely, a low central PP may indicate that those young men with isolated brachial hypertension have increased peripheral resistance in the presence of very compliant large arteries or absence of vascular aging, similar to those with the isolated diastolic hypertension defined by office or out-of-office measurements. 22 In women, the increase of the prevalence of brachial hypertension by the 2017 ACC/AHA criteria was mainly attributed to a high brachial systolic BP (≥130 mm Hg). Moreover, subjects with isolated central hypertension were mainly women and were characterized with a high central PP, a hall mark of vascular aging. 21 In a 9.4-year follow-up study in >4,000 community-dwelling men and women of 20-100 years of age, men and women had different longitudinal rate at which BP changed over time. 23 In men, at ages >40 years the rates of change in systolic BP and PP increase plateaued and then declined so that systolic BP also declined at older ages, whereas PP plateaued. 23 In women, systolic BP, diastolic BP, and mean BP increased at constant rates across all ages, producing an increasing rate of increase in PP. 23 Therefore, increased aortic stiffness is implicated in the age-associated increase in systolic BP and PP but a dissociation of arterial stiffness, PP, and systolic BP trajectories in men but not in women was observed. 23 In this study, we observed that diastolic BP and systolic BP contributed differently to the increase of the prevalence of brachial hypertension in men (47% due to isolated diastolic BP ≥ 80 mm Hg, Supplementary Figure 1) and women (44% due to isolated systolic BP ≥ 130 mm Hg, Supplementary  Figure 1) . Moreover, the prevalence of isolated central hypertension was higher than that of isolated brachial hypertension in elderly women but not in men across the age range (Figure 2) . Therefore, our results may support that sex and age modulate the BP trajectories. 23 
Limitations of the present study
This study was carried out in a speedy aging Chinese population. Therefore, the estimated impact of the 2017 ACC/AHA hypertension guideline on the prevalence of brachial hypertension may not apply to other populations. Our study used a type II device to measure central BP and identify the subgroups of isolated brachial hypertension and isolated central hypertension. Use of a type II central BP monitor purporting to measure invasive central BP may not be appropriate to investigate the difference between the central and brachial BP. 8 Our results may not be replicated in other population-based study when using a type I device which purports to give an estimate of central BP relative to measured brachial BP (i.e., relatively accurate pressure difference between central and peripheral sites). 8 We did not have the information about the kinds of antihypertensive medication, therefore, we could not evaluate the influence of specific antihypertensive drugs on central and peripheral BPs. In addition, we could not evaluate the association between unfit and hypertension, because we did not evaluate the physical function among our participants.
Adoption of the 2017 AHA/ACC BP thresholds substantially increases the prevalence of brachial hypertension, especially in men, and identifies more than 90% of those with central hypertension at the expense of lesser specificity. Measurement of central BP using a type II device may have add-on values in risk stratification in those with brachial hypertension, and screening central hypertension in those without brachial hypertension.
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